Supply Chain Risk and Middle Market Life Sciences Companies
Published on 21/04/2023
Supply chain risk remains top of mind for U.S.middle market life sciences companies, with 34% citing it as their biggest concern in a recent Chubb/National Center for the Middle Market survey. In fact, 51% say they were impacted by supply chain disruptions in the past six months. Chubb’s Lee Farrow explains what’s driving this issue. For more survey insights from the life sciences industry and resources to address these risks, visit: Middle Market Indicator: Year End 2022: Life Sciences
